Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Inflammation and AD: modulating microglia function focussing on TREM2 and CD33

PHAGO

Alzheimer’s disease (AD) is an age-related chronic neurodegenerative disease with four main pathological changes in the brain: amyloid plaques, fibrillary tau tangles, inflammation and neuronal loss. Phagocytes around amyloid plaques in late onset AD (LOAD) may be neurotoxic but have limited motility and phagocytic activity, suggesting a...

Funding Programme
Start Date
End Date
Total Funding
€ 18 088 176

Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases

IMPRiND

Assemblies of tau and α-synuclein were shown to spread along interconnected neuronal networks suggesting broadly relevant therapeutic directions for Alzheimer’s and Parkinson’s disease. This requires a pre-clinical stage of development that has yet to be met. The scale of neurodegenerative disease burden in Europe calls for an unprecedented...

Funding Programme
Start Date
End Date
Total Funding
€ 11 363 398
European Countries Involved

Initial Training Network for Neurogical disorders orchestrated by cytoKines

NEUROKINE

Neuroinflammatory disease, in particular multiple sclerosis affects more than 700.000 people within Europe alone. European countries are at the forefront of neuroimmunological research and students in medicine and biology are greatly attracted by the field. Neuroimmunology research further impacts our understanding of the ethiopathology of other...

Funding Programme
Start Date
End Date
Total Funding
€ 3 536 796

Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain

IM2PACT

The overall aim is to further the understanding of the BBB in health and disease states towards the development of innovative brain delivery systems, especially for biopharmaceuticals (e.g., peptides, antibodies, etc.) and the identification of novel disease drug targets (Alzheimer’s Disease, MS, metabolic disease).

The related key deliverables...

Funding Programme
Start Date
End Date
Total Funding
€ 17 410 136

Investigating the impact of meditation training on mental health and wellbeing in the ageing population

MEDIT-AGEING

As the number of older people in Europe grows, increasing healthy life years is a priority. Cognitive decline, dementia (e.g. Alzheimer’s disease, AD), sleep disturbances and depression, all related to psychological distress and anxiety, are significant drivers of reduced quality of life in older adults. This project builds on evidence that...

Funding Programme
Start Date
End Date
Total Funding
€ 7 087 230
European Countries Involved

Luminescent polymers for in vivo imaging of amyloid signatures

LUPAS

In this project we seek to develop new smart imaging molecular tools for combating neurodegenerative diseases such as Alzheimer’s disease and prion diseases. Emphasis is put on translational applied research for the development and validation of novel properly functionalized luminescent conjugated polymers (LCP) that via modern imaging technology...

Funding Programme
Start Date
End Date
Total Funding
€ 6 475 643
European Countries Involved

MED-GUIDE

MED-GUIDE

MedGUIDE is a European innovation project that provides an innovative approach to support seniors with dementia with their medication adherence through smart pill boxes and social networking. The project aims to help elders with mild cognitive impairments living at home

Funding Programme
Start Date
End Date
Total Funding
€ 2 039 024
European Countries Involved

Mobility Safeguarding Assistance Service with Community Functionality for People with Dementia

CONFIDENCE

The aim of CONFIDENCE is to develop a community-based mobility safeguarding assistance service for people suffering from mild to moderate dementia. CONFIDENCE combines “assistive technologies” with “personal help”. The CONFIDENCE service is built around a “virtual companion” providing different levels of assistance, depending on the situational...

Funding Programme
Start Date
End Date
Total Funding
€ 2 820 158
European Countries Involved

Modelling and Inference on brain Networks for Diagnosis

MIND

Graphs are used in modern neuroscience to represent structural and functional connectivity of the brain acquired using magnetic resonance imaging. A number of pathologies affect these networks: their study holds vast promise for understanding and diagnosing brain diseases. But brain connectivity data is not trivial to process, and the predominant...

Funding Programme
Start Date
End Date
Total Funding
€ 275 363
European Countries Involved

Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis

MIRIADE

Dementia is currently diagnosed largely based on cognitive decline, while pathology starts years before symptom onset. To make progress in the development of effective drugs for dementia, there is an urgent need for biomarkers to enable precision health: for early and specific diagnosis and objective monitoring of disease progression. With its...

Funding Programme
Start Date
End Date
Total Funding
€ 4 034 565

NAD+ International Scientist-training

NADIS

Nicotinamide adenine dinucleotide (NAD+) is a central redox cofactor and the limiting substrate of key metabolic enzymes. The constellation of cellular functions in which NAD+ is involved makes its availability critical for cell survival, and its depletion is a leading factor in a number of diseases in humans, ranging from rare inherited defects to...

Funding Programme
Start Date
End Date
Total Funding
€ 2 530 832
European Countries Involved

Nanosystems for the early Diagnosis of Neurodegenerative diseases

NADINE

Medical diagnosis is currently undergoing a major revolution due to the fast discovery of molecular biomarkers, and the development of multimodal “metabiomarker” signatures. Progress, however, is hindered by low abundance of many biomarkers of interest in body fluids, in absolute concentration and with regard to other biomolecules. The aim of the...

Funding Programme
Start Date
End Date
Total Funding
€ 11 702 928
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).